I think they can support up until Malta. We can take that avenue if required, however, and the Latin American announcement/connection gives us a hint of possible alternative supply options if required. 700 patients at $10k per patient pa is still $7m revenue, which is quite impressive after a few months. Let's see how the growth continues, but the recent market expansion only opens us up to stronger growth.
MXC Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
